Sugi Predict

Sugi Predict / Compounds / SCHEMBL22556591

SCHEMBL22556591

SCHEMBL22556591

CC(C)N(CCc1nnc(-c2ccccc2Nc2ccc(C(F)(F)F)cc2)o1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 1/20 0.40
▸ DDX3X O00571 1/20 0.39
▸ TP53 P04637 2/20 0.38
▸ FLT1 P17948 3/20 0.35
▸ KDR P35968 3/20 0.35
▸ PSMB5 P28074 1/20 0.35
▸ THRB P10828 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ ACKR3 P25106 1/20 0.33
▸ MGAM O43451 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ SI P14410 1/20 0.33
▸ MGAM2 Q2M2H8 1/20 0.33
▸ CTSV O60911 1/20 0.33
▸ CTSB P07858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22556530 0.92 ABCG2 (0.41) ABCG2DDX3XTP53FLT1KDR
SCHEMBL22556425 0.90 ABCG2 (0.41) ABCG2DDX3XTP53FLT1KDR
SCHEMBL23701623 0.90 ABCG2 (0.41) ABCG2DDX3XTP53FLT1KDR
SCHEMBL22556540 0.88 DDX3X (0.41) ABCG2DDX3XTP53FLT1KDR
SCHEMBL22556585 0.86 DDX3X (0.43) ABCG2DDX3XTP53FLT1KDR
SCHEMBL25190469 0.85 ABCG2 (0.39) ABCG2DDX3XTP53FLT1KDR
SCHEMBL22556545 0.85 ABCG2 (0.40) ABCG2DDX3XTP53FLT1KDR
SCHEMBL22556347 0.84 ABCG2 (0.42) ABCG2DDX3XTP53FLT1KDR
SCHEMBL22556363 0.83 ABCG2 (0.41) ABCG2DDX3XTP53FLT1KDR
SCHEMBL22556434 0.83 ABCG2 (0.41) ABCG2DDX3XTP53FLT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11661403-B2 Oxadiazole compounds VIVACE THERAPEUTICS, INC. (US) 2023-05-30 — — US disclosed
US-11661403-B2 Oxadiazole compounds VIVACE THERAPEUTICS, INC. (US) 2023-05-30 — — US disclosed
US-11661403-B2 Oxadiazole compounds VIVACE THERAPEUTICS, INC. (US) 2023-05-30 — — US disclosed
US-20210238154-A1 OXADIAZOLE COMPOUNDS VIVACE THERAPEUTICS, INC. 2021-08-05 — — US disclosed
US-20210238154-A1 OXADIAZOLE COMPOUNDS VIVACE THERAPEUTICS, INC. 2021-08-05 — — US disclosed
EP-3793551-A1 OXADIAZOLE COMPOUNDS Vivace Therapeutics, Inc. (US) 2021-03-24 — — EP disclosed
WO-2019222431-A9 OXADIAZOLE COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2020-10-22 — — WO disclosed
WO-2019222431-A9 OXADIAZOLE COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2020-10-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238154-A1 OXADIAZOLE COMPOUNDS YAP1, TEAD2, TEAD3 ABCG2 2985/4885DDX3X 611/4885TP53 4/4885
US-11661403-B2 Oxadiazole compounds YAP1, TEAD2, TEAD3 ABCG2 2985/4885DDX3X 611/4885TP53 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.